Zofia E. Dziewanowska

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

Andrew Webb, David Cunningham, Finbarr E. Cotter et al. · The Lancet · 1997 · 498 citations

Medicine, Cancer Biology, Oncology +13

First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial

Amy Webb, David Cunningham, Finbarr E. Cotter et al. · European Journal of Cancer · 1997 · 320 citations

Medicine, Oncology, Pharmacology +12

Circadian changes in the bioavailability and effects of indomethacin in healthy subjects

J. Clench, Alain Reinberg, Zofia E. Dziewanowska et al. · European Journal of Clinical Pharmacology · 1981 · 114 citations

Nursing, Pharmacokinetics, Pharmacology +9

Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II

George R. Blumenschein, Fadlo R. Khuri, Joachim von Pawel et al. · Journal of Clinical Oncology · 2008 · 96 citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT I

Rodryg Ramlau, Petr Zatloukal, Jacek Jassem et al. · Journal of Clinical Oncology · 2008 · 90 citations · Full text

Medicine, Oncology, Pharmacology +10